Literature DB >> 10065142

The influence of field size and other radiotherapy parameters on acute toxicity in pharyngolaryngeal cancers.

R Miralbell1, A S Allal, B Mermillod, B Pastoors.   

Abstract

BACKGROUND: Accelerated radiotherapy and/or chemo-radiotherapy of the head and neck region decrease the tolerance of acute responding tissues. Tissue tolerance is also field size dependent. PATIENTS AND
METHOD: An attempt to retrospectively quantify the risk of acute toxicity (peak scores) with field size was undertaken in 286 patients irradiated for unresected head and neck tumors with or without chemotherapy, and with or without accelerated radiotherapy between 1979 and 1990. A Grade-3 to -4 acute toxicity score (RTOG) and > 5% weight loss were chosen as endpoints.
RESULTS: For Grade-3 to -4 toxicity, the risk increased from 0.06 for 5 x 5 cm2 to 0.68 for 17 x 17 cm2 fields and conventional radiotherapy, and from 0.33 for 5 x 5 cm2 to 0.94 for 17 x 17 cm2 and multiple daily fractionation. For > 5% weight loss, the risk ranged from 0.07 for 5 x 5 cm2 to 0.94 for 17 x 17 cm2 fields.
CONCLUSIONS: The size of the cervical fields receiving the first 50 Gy was an indicator for severe acute toxicity and weight loss. Taking these data into account may help to improve preventive and treatment measures.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10065142     DOI: 10.1007/bf02753846

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  11 in total

1.  Simultaneous chemoradiation in the treatment of advanced head and neck cancer.

Authors:  M C Weissler; S Melin; S L Sailer; B F Qaqish; J G Rosenman; H C Pillsbury
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1992-08

2.  Early and long-term results of an original accelerated radiation therapy schedule in head and neck carcinoma.

Authors:  A S Allal; R Miralbell; G Pipard; C Guillemin; W Lehmann; J M Kurtz
Journal:  Acta Oncol       Date:  1997       Impact factor: 4.089

3.  A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer.

Authors:  S M Jackson; L M Weir; J H Hay; V H Tsang; J S Durham
Journal:  Radiother Oncol       Date:  1997-04       Impact factor: 6.280

4.  A unified approach to dose-effect relationships in radiotherapy. I: Modified TDF and linear quadratic equations.

Authors:  C G Orton; L Cohen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-03       Impact factor: 7.038

5.  Combined concomitant boost radiotherapy and chemotherapy in stage III-IV head and neck carcinomas: a comparison of toxicity and treatment results with those observed after radiotherapy alone.

Authors:  A S Allal; S Bieri; R Miralbell; P Dulguerov; A Bardina; W Lehmann; J M Kurtz
Journal:  Ann Oncol       Date:  1997-07       Impact factor: 32.976

Review 6.  Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.

Authors:  G W Barendsen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-11       Impact factor: 7.038

7.  Implications of the quadratic cell survival curve and human skin radiation "tolerance doses" on fractionation and superfractionation dose selection.

Authors:  B G Douglas
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-07       Impact factor: 7.038

8.  Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.

Authors:  J C Horiot; P Bontemps; W van den Bogaert; R Le Fur; D van den Weijngaert; M Bolla; J Bernier; A Lusinchi; M Stuschke; J Lopez-Torrecilla; A C Begg; M Pierart; L Collette
Journal:  Radiother Oncol       Date:  1997-08       Impact factor: 6.280

9.  Twice-a-day radiation therapy for cancer of the head and neck.

Authors:  C C Wang; P H Blitzer; H D Suit
Journal:  Cancer       Date:  1985-05-01       Impact factor: 6.860

10.  Time-dependent tumour repopulation factors in linear-quadratic equations--implications for treatment strategies.

Authors:  R G Dale
Journal:  Radiother Oncol       Date:  1989-08       Impact factor: 6.280

View more
  2 in total

1.  Clinical effects of flurbiprofen tooth patch on radiation-induced oral mucositis. A pilot study.

Authors:  M A Stokman; F K L Spijkervet; F R Burlage; J L N Roodenburg
Journal:  Support Care Cancer       Date:  2004-09-09       Impact factor: 3.603

2.  Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial.

Authors:  M A Stokman; F K L Spijkervet; F R Burlage; P U Dijkstra; W L Manson; E G E de Vries; J L N Roodenburg
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.